Natural Product: NPC325976

Natural Product IDNPC325976
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Tyrocidine C
IUPAC Name 3-[(3R,6S,9S,12S,15S,18S,21S,24R,27S,30S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3-benzyl-15-[(4-hydroxyphenyl)methyl]-24,27-bis(1H-indol-3-ylmethyl)-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-propan-2-yl-1,4,7,10,13,16,19,22,25,28-decazabicyclo[28.3.0]tritriacontan-18-yl]propanamide
Synonyms Tyrocidine C
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL576465
PubChem CID 45485349
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000348] Peptides
            • [CHEMONTID:0004831] Oligopeptides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey NJMWWUADORPGGY-AJOXBXEMSA-N
Standard InCHI InChI=1S/C70H89N15O13/c1-38(2)30-51-63(91)83-56(32-40-14-6-5-7-15-40)70(98)85-29-13-21-57(85)68(96)82-54(34-43-37-75-48-19-11-9-17-46(43)48)65(93)80-53(33-42-36-74-47-18-10-8-16-45(42)47)64(92)81-55(35-59(73)88)66(94)76-50(26-27-58(72)87)62(90)79-52(31-41-22-24-44(86)25-23-41)67(95)84-60(39(3)4)69(97)77-49(20-12-28-71)61(89)78-51/h5-11,14-19,22-25,36-39,49-57,60,74-75,86H,12-13,20-21,26-35,71H2,1-4H3,(H2,72,87)(H2,73,88)(H,76,94)(H,77,97)(H,78,89)(H,79,90)(H,80,93)(H,81,92)(H,82,96)(H,83,91)(H,84,95)/t49-,50-,51-,52-,53+,54-,55-,56+,57-,60-/m0/s1
SMILES NCCC[C@@H]1N=C(O)[C@@H](N=C(O)[C@H](Cc2ccc(cc2)O)N=C(O)[C@H](CCC(=N)O)N=C(O)[C@H](CC(=N)O)N=C(O)[C@H](N=C([C@@H](N=C([C@H]2N(C(=O)[C@H](N=C([C@@H](N=C1O)CC(C)C)O)Cc1ccccc1)CCC2)O)Cc1c[nH]c2c1cccc2)O)Cc1c[nH]c2c1cccc2)C(C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   1347.68 Volume:   1361.5
?
Van der Waals volume.
Dense:   0.99 LogP:   0.245
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   0.985
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.317
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   19.0 Rigid Bonds:   69.0
TPSA:   479.61
?
Topological Polar Surface Area.
H-Bond Acceptor:   28.0
H-Bond Donor:   18.0 Rings:   8.0
Heavy Atoms:   28.0

MedChem Properties

QED Drug-Likeness Score:   0.026 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.751 Fsp3:   0.429
MCE-18:   189.08
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.999 Fluc inhibitor:   0.268
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.185
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.897
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.004 Promiscuous compounds:   0.262

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.33 MDCK Permeability:   -5.192
Pgp-inhibitor:   0.813 Pgp-substrate:   1.0
PAMPA:   0.989
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.057
20% Bioavailability (F20%):   1.0 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.749
Plasma Protein Binding (PPB):   68.064% Volume Distribution (VD):   -0.274
Fu: 28.806%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.978 BCRP inhibitor:   0.025
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.052
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  -0.315 Half-life (T1/2):  2.976

ADMET: Toxicity

hERG Blockers:  0.0 hERG Blockers (10um):  0.0
Human Hepatotoxicity (H-HT):  1.0 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  0.002 Rat Oral Acute Toxicity:  0.98
Maximum Recommended Daily Dose:  0.962 Skin Sensitization:  1.0
Carcinogencity:  0.227 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.614
Drug-induced Neurotoxicity:  0.167 Ototoxicity:  1.0
Hematotoxicity:  0.696 Drug-induced Nephrotoxicity:  1.0
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.0
A549 Cytotoxicity:  0.0 Hek293 Cytotoxicity:  0.0
BCF:   0.216
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.348
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.979
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.952
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO23673 Brevibacillus brevis Species Paenibacillaceae Bacteria n.a. n.a. n.a. PMID[4320358]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT729 Organism Micrococcus luteus Micrococcus luteus IC50 = 6400.0 nM PMID[19586775]
NPT729 Organism Micrococcus luteus Micrococcus luteus ICmax = 9.0 uM PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes Activity = 1.48 % PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes Activity = 66.0 % PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes IC50 = 9500.0 nM PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes ICmax = 13.0 uM PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes IC50 = 7000.0 nM PMID[19586775]
NPT564 Organism Listeria monocytogenes Listeria monocytogenes ICmax = 11.0 uM PMID[19586775]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference
Listeria monocytogenes n.a. T1/2 = 0.52 hr PMID[19586775]





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC325976 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC326363
0.7981 Intermediate Similarity NPC328649
0.7863 Intermediate Similarity NPC489555
0.7027 Intermediate Similarity NPC31385
0.6609 Remote Similarity NPC110602
0.6609 Remote Similarity NPC479071
0.6555 Remote Similarity NPC479076
0.6522 Remote Similarity NPC484874
0.6356 Remote Similarity NPC479075
0.6333 Remote Similarity NPC479073
0.6218 Remote Similarity NPC162860
0.6179 Remote Similarity NPC75726
0.6026 Remote Similarity NPC479141
0.5984 Remote Similarity NPC479065
0.5968 Remote Similarity NPC479066
0.5789 Remote Similarity NPC489625
0.5726 Remote Similarity NPC293917
0.5714 Remote Similarity NPC479574
0.5702 Remote Similarity NPC241794
0.5691 Remote Similarity NPC155143
0.5656 Remote Similarity NPC54420
0.5548 Remote Similarity NPC75634
0.5546 Remote Similarity NPC107077
0.5546 Remote Similarity NPC483341
0.5538 Remote Similarity NPC100321
0.5537 Remote Similarity NPC223791
0.5536 Remote Similarity NPC487314
0.5529 Remote Similarity NPC477634
0.5505 Remote Similarity NPC202198
0.5489 Remote Similarity NPC483985
0.5455 Remote Similarity NPC486515
0.5455 Remote Similarity NPC489829
0.5431 Remote Similarity NPC482066
0.5422 Remote Similarity NPC484965
0.5412 Remote Similarity NPC485244
0.5391 Remote Similarity NPC136797
0.5357 Remote Similarity NPC479072
0.5291 Remote Similarity NPC477633
0.5273 Remote Similarity NPC489225
0.5269 Remote Similarity NPC477635
0.5268 Remote Similarity NPC314603
0.5259 Remote Similarity NPC486528
0.5253 Remote Similarity NPC320968
0.5226 Remote Similarity NPC153400
0.5207 Remote Similarity NPC486506
0.5207 Remote Similarity NPC485247
0.5207 Remote Similarity NPC486514
0.5197 Remote Similarity NPC284549
0.5139 Remote Similarity NPC484875
0.5134 Remote Similarity NPC479872
0.5126 Remote Similarity NPC213629
0.512 Remote Similarity NPC489538
0.5109 Remote Similarity NPC69843
0.5094 Remote Similarity NPC17059
0.5081 Remote Similarity NPC487116
0.503 Remote Similarity NPC489535

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC325976 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7232 Intermediate Similarity NPD8405 Pre-clinical
0.5726 Remote Similarity NPD7621 Clinical (unspecified phase)
0.5255 Remote Similarity NPD8493 Clinical (unspecified phase)
0.5041 Remote Similarity NPD7948 Phase 1

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data